Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Actelion Looks Within as Competition Lifts Drug Prices
Bloomberg
Monday, February 18, 2013 - 12:24pm
tags:
Actelion, pulmonary arterial hypertension, PAH, Tracleer
Vasella’s $78 Million Novartis Payout Boosts ‘Fat-Cat’ Crackdown
Bloomberg
Monday, February 18, 2013 - 12:22pm
tags:
Daniel Vasella, Novartis, executive pay
Anything Can Happen This Year For Celldex
Seeking Alpha
Monday, February 18, 2013 - 12:18pm
tags:
Celldex, breast cancer, CDX-110, CDX-111, Seattle Genetics
Omeros Corporation's Stock Has Potential To Double This Year
Seeking Alpha
Monday, February 18, 2013 - 12:13pm
tags:
Omeros, OMS302
What to Expect from DepoMed
Motley Fool
Monday, February 18, 2013 - 12:04pm
tags:
Depomed, earnings
NovaBay's Sugar Daddy, Galderma, Pushes Impetigo Treatment
Seeking Alpha
Monday, February 18, 2013 - 12:04pm
tags:
Galderma, impetigo, NovaBay Pharmaceuticals, NVC-422, South Africa
Pharmacyclics Still on a Roll After Earnings Results
Motley Fool
Monday, February 18, 2013 - 12:00pm
tags:
Pharmacyclics, earnings
Pfizer's Long Term Strategy: A Possible Breakup
Seeking Alpha
Monday, February 18, 2013 - 11:59am
tags:
Pfizer
Biomarin: This Mid-Cap Pharmaceutical is a Prime Takeover Target
Motley Fool
Monday, February 18, 2013 - 11:56am
tags:
M&A, Biomarin, Sanofi, Genzyme
Pfizer: Increasing Income Makes It A Buy
Seeking Alpha
Monday, February 18, 2013 - 11:54am
tags:
Pfizer
Does the Arthritis Market Have Growing Pains?
Motley Fool
Monday, February 18, 2013 - 11:53am
tags:
rheumatoid arthritis, TNF blockers, Humira, AbbVie, Pfizer, Xeljanz
Better Buy: Pfizer or Zoetis?
Motley Fool
Sunday, February 17, 2013 - 1:11pm
tags:
Pfizer, Zoetis
1 Weak Link at This Big Pharma (video)
Motley Fool
Sunday, February 17, 2013 - 12:20pm
tags:
Eli Lilly
US FDA approves Teva Pharma's ANDA for generic Adderall XR
Pharmabiz
Sunday, February 17, 2013 - 12:16pm
tags:
Teva Pharmaceuticals, generics, Adderall XR
China Biotech In Review: Amgen To Build China Presence With Partnerships / M&A
Seeking Alpha
Sunday, February 17, 2013 - 12:07pm
tags:
M&A, Shenghuo Pharmaceutical Holdings, Shanshi Medical Device, Amgen, OxOnc Development, Celgene
Will There Ever Be an Obesity Drug Blockbuster?
Motley Fool
Sunday, February 17, 2013 - 12:02pm
tags:
obesity, weight loss, Arena Pharmaceuticals, Eisai, Belviq, Qsymia, Orexigen
Progenics Pharmaceuticals Presents Updated Data From Phase 1 Study of PSMA ADC
Pipeline Review
Sunday, February 17, 2013 - 11:58am
tags:
PSMA ADC, prostate cancer, Progenics Pharmaceuticals
Momenta Pharmaceuticals sticks to guidance despite revenue plunge
bizjournals
Sunday, February 17, 2013 - 11:54am
tags:
Momenta, earnings
Has Avanir Pharmaceuticals Become the Perfect Stock?
Motley Fool
Sunday, February 17, 2013 - 11:52am
tags:
Avanir
Does the Arthritis Market Have Growing Pains?
Motley Fool
Sunday, February 17, 2013 - 11:51am
tags:
rheumatoid arthritis, AbbVie, Pfizer, Merck, JNJ, Amgen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.